Remicade (infliximab) - J&J
Rituxan (rituximab) - Roche
Humira (adalimumab) - AbbVie
tofacitinib - Generic mfg.
Kineret (anakinra) - SOBI
Stelara (ustekinumab) - J&J
Simponi (golimumab) - Merck (MSD), Mitsubishi Tanabe, J&J
Stalaris (efzofitimod) - aTyr Pharma, Kyorin
Kevzara (sarilumab) - Asahi Kasei, Regeneron, Sanofi
https://scientific.sparx-ip.net/archiveeular/?view=2&c=a&item=2024AB0785
 
K. Bechman1; K. He2; A. Miracle2; K. Biddle3; J. Galloway1
 
May 30, 2024
 
Prev Next